Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling

scientific article

Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/CARCIN/BGS127
P698PubMed publication ID22436611

P2093author name stringSheng-Chu Kuo
Tur-Fu Huang
Jin-Cherng Lien
Shiu-Wen Huang
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectendotheliumQ111140
angiogenesis inhibitorQ574834
P304page(s)1022-1030
P577publication date2012-03-20
P1433published inCarcinogenesisQ326022
P1476titleAntiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling
P478volume33

Reverse relations

cites work (P2860)
Q53788180Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models.
Q28535457Anti-cancer activity of an osthole derivative, NBM-T-BMX-OS01: targeting vascular endothelial growth factor receptor signaling and angiogenesis
Q52675240Antiangiogenic Effects of VH02, a Novel Urea Derivative: In Vitro and in Vivo Studies.
Q53057689Antiangiogenic effects of cucurbitacin-I.
Q37534643Comparative Evaluation of TRAIL, FGF-2 and VEGF-A-Induced Angiogenesis In Vitro and In Vivo
Q37665271DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling
Q38887615FGFs: crucial factors that regulate tumour initiation and progression.
Q36026159Functionalized Benzimidazole Scaffolds: Privileged Heterocycle for Drug Design in Therapeutic Medicine.
Q33697011Identification of protein targets in cerebral endothelial cells for brain arteriovenous malformation (AVMs) molecular therapies
Q34914220PPemd26, an anthraquinone derivative, suppresses angiogenesis via inhibiting VEGFR2 signalling
Q39027159Synthesis, biological evaluation, and docking studies of new 2-furylbenzimidazoles as anti-angiogenic agents: part II.
Q89697165Targeting Receptor Tyrosine Kinase VEGFR-2 in Hepatocellular Cancer: Rational Design, Synthesis and Biological Evaluation of 1,2-Disubstituted Benzimidazoles
Q35238403WMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-angiogenic activities via Src-homology-2-domain-containing protein tyrosine phosphatase 1

Search more.